Pay in 4 interest-free payments of $25.29 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
in which the two hydroxy groups of GLYCEROL are esterified with fatty acids
NIBR3049 shows moderate activity in this cellular assay (IC50=689 nM
56(9):1435-50
17(2):195-203
such as NODI and NOD2
Cebranopadol - CAS# 863513-91-1 suquidar in which the two hydroxyCebranopadol, also known as GRT 6005, is a Opioid Receptor Agonist with agonistic activity at nociceptin orphanin FQ and opioid receptors. Cebranopadol displays analgesic, antiallodynic and antihyperalgesic properties in several rat models of acute nociceptive, inflammatory, cancer and neuropathic pain. In contrast to classical opioids, it has a higher analgesic potency in models of neuropathic pain than in acute nociceptive pain. Even at higher
US$ 42.00
US$ 704.48
US$ 38.95